tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Liav Abraham, 49 are a BUY (76.56%), 13 are a HOLD (20.31%), 2 are a SELL (3.13%).
Analyst Liav Abraham, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 57.5% that have a potential upside of 19.46% achieved within 315 days. Previously, Liav Abraham worked at CITI.
Liav Abraham’s has documented 138 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on JAZZ, Jazz Pharmaceuticals PLC at 24-Nov-2025.
Analyst best performing recommendations are on INSM (INSMED).
The best stock recommendation documented was for TEVA (TEVA PHARMA INDUSTRIES LTD ADR) at 5/1/2018. The price target of $24 was fulfilled within 42 days with a profit of $5.29 (28.27%) receiving and performance score of 6.73.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 21-Apr-2020
$193
$-0.02 (-0.01%)
$178
5 years 8 months 21 days ago
(21-Apr-2020)
2/8 (25%)
$8.96 (4.87%)
125
Buy
$203
5 years 10 months 24 days ago
(18-Feb-2020)
1/2 (50%)
$20.22 (11.61%)
95
Hold
Since 30-Jan-2019
$203
$9.98 (5.17%)
$178
5 years 11 months 1 days ago
(10-Feb-2020)
5/16 (31.25%)
$4.87 (2.46%)
74
Hold
Since 22-Jan-2020
$188
5 years 11 months 20 days ago
(22-Jan-2020)
2/11 (18.18%)
$50.95 (37.18%)
254
Hold
Since 19-Nov-2019
$200
6 years 1 months 23 days ago
(19-Nov-2019)
2/11 (18.18%)
$73.92 (58.63%)
290
Which stock is Liav Abraham is most bullish on?
What Year was the first public recommendation made by Liav Abraham?
